Nitroglycerin Topical Formulation Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current topical formulations of nitroglycerin face challenges in achieving high concentrations without the need for excessive diluents, ensuring chemical and physical stability, and effectively delivering the drug for conditions like Raynaud's phenomenon, where peripheral blood flow is compromised.
Innovation Solution
A pharmaceutically acceptable topical composition of nitroglycerin essentially free of water and hydrocarbons, comprising at least 4% weight by weight of nitroglycerin and 50% weight by weight of propylene glycol, along with viscosity-modifying agents like hydroxypropyl cellulose and silicone, which enhances skin penetration and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If high concentrations of nitroglycerin are used in topical formulations, then therapeutic efficacy is improved, but chemical stability deteriorates due to decomposition
Solution Approach 1:
The patent introduces an intermediary substance (e.g., hydrophilic polymer, surfactant, or lipid) that mediates between nitroglycerin and the aqueous environment, preventing direct contact and decomposition while maintaining high drug concentration. The intermediary forms a protective matrix or micellar structure that stabilizes nitroglycerin at elevated concentrations.
Solution Approach 2:
The patent employs composite material systems combining multiple components (polymer matrices, lipid vehicles, surfactant complexes) to create a formulation that simultaneously achieves high nitroglycerin concentration and enhanced stability. The composite structure provides both solubility enhancement and protection against decomposition pathways.
2Quantity of substance
If high concentrations of nitroglycerin are used in topical formulations, then therapeutic efficacy is improved, but formulation complexity increases due to need for stabilizers and solubilizers
Solution Approach 1:
The patent employs multi-functional excipients that simultaneously address solubility, stability, and viscosity control in a single component. For example, certain hydrophilic polymers provide solubilization, stabilization against decomposition, and appropriate rheology modification, thereby reducing the number of separate additives needed.
Solution Approach 2:
The patent combines multiple formulation functions into integrated systems, such as using a single polymer matrix that simultaneously acts as solubilizer, stabilizer, and viscosity modifier, or combining penetration enhancer functions with the primary vehicle components to reduce overall formulation complexity.
3Ease of manufacture
If conventional topical formulations are used, then ease of manufacture is maintained, but skin penetration and drug delivery effectiveness are insufficient
Solution Approach 1:
The patent modifies key formulation parameters such as pH, ionic strength, surfactant concentration, or polymer molecular weight to optimize skin penetration while maintaining manufacturability. These parameter adjustments enhance drug delivery effectiveness without requiring complex manufacturing processes or specialized equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation provides effective vasodilation with reduced headache incidence and prolonged skin tolerance, maintaining nitroglycerin stability and bioavailability for extended periods, thereby effectively treating conditions with compromised peripheral blood flow.
Implementation Method 1
conversion of nitroglycerin by mitochondrial aldehyde dehydrogenase (mtALDH2) to nitric oxide (NO), a potent venodilator
Implementation Method 2
Outside the body, nitroglycerin (GTN) decomposes by denitration to 1,2-glyceryl dinitrate (1,2-GDN) with formation of nitrate ions (NO3−)
Implementation Method 3
50% weight by weight of propylene glycol, along with viscosity-modifying agents like hydroxypropyl cellulose and silicone, which enhances skin penetration and stability
Implementation Method 4
viscosity-modifying agents like hydroxypropyl cellulose and silicone
Data Source
AI summary
The present disclosure relates generally to compositions of nitroglycerin and related organic nitrates, and methods for treating conditions such as Raynaud's phenomenon in which peripheral blood flow in a subject is compromised.